Wiwin Dwi Rahmadani Tukloy, '- (2021) Studi Penggunaan Multivitamin Dan Suplemen Pada Pasien Covid-19 Derajat Ringan-Sedang (Penelitian dilakukan di RS Bhayangkara Surabaya). Skripsi thesis, Universitas Airlangga.

	Text (HALAMAN DEPAN) 1 HALAMAN DEPAN.pdf Download (2MB)
	Text (ABSTRAK) 2 ABSTRACT.pdf Download (130kB)
	Text (DAFTAR ISI) 3 DAFTAR ISI.pdf Download (187kB)
	Text (BAB I PENDAHULUAN) 4 BAB I PENDAHULUAN.pdf Download (169kB)
	Text (BAB II TINJAUAN PUSTAKA) 5 BAB II TINJAUAN PUSTAKA.pdf Restricted to Registered users only Download (3MB) | Request a copy
	Text (BAB III KERANGKA KONSEP) 6 BAB III KERANGKA KONSEP.pdf Restricted to Registered users only Download (377kB) | Request a copy
	Text (BAB IV METODE PENELITIAN) 7 BAB IV METODE PENELITIAN.pdf Restricted to Registered users only Download (126kB) | Request a copy
	Text (BAB V HASIL PENELITIAN) 8 BAB V HASIL PENELITIAN DAN PEMBAHASAN.pdf Restricted to Registered users only Download (392kB) | Request a copy
	Text (BAB VI KESIMPULAN DAN SARAN) 9 BAB VI KESIMPULAN DAN SARAN.pdf Restricted to Registered users only Download (108kB) | Request a copy
	Text (DAFTAR PUSTAKA) 10 DAFTAR PUSTAKA.pdf Download (162kB)
	Text (LAMPIRAN) 11 LAMPIRAN.pdf Restricted to Registered users only Download (3MB) | Request a copy
	Text (KESEDIAAN PUBLIKASI) KESEDIAAN PUBLIKASI.pdf Restricted to Registered users only Download (128kB) | Request a copy

Abstract

The purpose of this study was to determine the effectiveness of using multivitamins and supplements on the length of stay of Patients with mild-moderate COVID-19 in the form of improved clinical and laboratory data. This is an observational with descriptive analysis using patient medical records in the period December 2020 to February 2021. The inclusion criteria in this study were mildmoderate COVID-19 patients who received protocols of therapy A (Azytromycin), B (Levofloxacin), and C (Switch antibiotic) along with the administration of Multivitamins and Supplements and Favipiravir as antiviral. The results showed that majority of patients were mild 17(71%) and moderate 19(83%) using multivitamins and zinc minerals (po). Short duration of mild patients with the use of vitamin C 200mg/ml (iv drip), vitamin E 200IU (po), and zinc 20mg (po) in therapy A (7 days), B (9 days), C (6 days). While the moderate patients for therapy A (8 days) with vitamin C 200mg/ml (iv drip), vitamin E 200IU (po), and zink 20mg (po) and multivitamins and zinc minerals (po). For therapy B (8 days) and C (9 days) with vitamin C 200mg/ml (iv drip), vitamin E 200IU (po), vitamin D3 1000IU (po), and zinc 20mg (po) as well as multivitamins and zinc minerals. Multivitamins and supplements as an effective support therapy because there are give a shorten the length of hospitalization. It is necessary to review the use of each content of multivitamins and supplements in the form of effective doses and carried out in a larger number of samples

Actions (login required)

View Item